Structural aberrations of chromosomal band 13q14 are frequent in B-cell chronic lymphocytic leukemia (B-CLL) and target a putative tumor suppressor gene in the genomic region between the RB1 gene and the genetic marker D13S25. Recently, it has been suggested that alterations of this particular regio
14Q+ CHROMOSOME MARKER IN A T-CELL-RICH B-CELL LYMPHOMA
β Scribed by LA STARZA, ROBERTA; AVENTIN, ANA; FALZETTI, DANIELA; STUL, MICHEL; MARTELLI, MASSIMO F.; FALINI, BRUNANGELO; MECUCCI, CRISTINA
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 517 KB
- Volume
- 178
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
β¦ Synopsis
Cytogenetic, in situ hybridization, and molecular studies were performed in a case of T-cell-rich B-cell lymphoma. Demonstration of Ig gene rearrangements for both heavy and light chains confirmed the B-lineage restriction of the neoplastic cell population. Moreover, as expected in B-cell malignancies, all abnormal karyotypes showed a 14q+ chromosome marker involving 14q32. The origin of the extra material on the derivative 14q+, as defined by chromosome painting with a library for chromosome 11, and Southern blotting for c-myc and bcl-2 rearrangements, remains unknown.
π SIMILAR VOLUMES
## Abstract Chromosome analysis using banding staining techniques was carried out on cells from a Bβcell acute lymphocytic leukemia (ALL) of the Burkitt type and a case of nonβendemic Burkitt lymphoma presenting as ALL. In both patients a marker chomoβsome 14q+ was found which was morphologically i
Eight years prior to the current admission, this 67-yr-old white male was diagnosed with a diffuse large-cell non-Hodgkin's lymphoma. During the course of his disease the patient received several courses of chemotherapy for multiple relapses. Following a course of high dose chemotherapy consisting o
We describe a t(8; I4)(q24;q I I) involving the T-cell receptor a-chain gene (TCRA) and the 3' region of the MYC protooncogene in a B-cell lymphoma. The 6-cell origin of this tumor was determined by its histological architecture, by immunophenotypic analysis, and by Southern analysis of immunoglobul
## Abstract Angioimmunoblastic Tβcell lymphoma (AILT) is a histopathologically wellβdefined entity. However, despite a number of cytogenetic studies, the genetic basis of this lymphoma entity is not clear. Moreover, there is an overlap to some cases of peripheral Tβcell lymphoma unspecified (PTCLβu